These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27732798)

  • 21. Targeted Degradation of Proteins by PROTACs.
    Jang ER; Lee W; Kim KB
    Curr Protoc Chem Biol; 2010 Jun; 2(2):71-87. PubMed ID: 23836551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation.
    Wang X; Feng S; Fan J; Li X; Wen Q; Luo N
    Biochem Pharmacol; 2016 Sep; 116():200-9. PubMed ID: 27473774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monomeric Targeted Protein Degraders.
    Hanan EJ; Liang J; Wang X; Blake RA; Blaquiere N; Staben ST
    J Med Chem; 2020 Oct; 63(20):11330-11361. PubMed ID: 32352776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteolysis-Targeting Chimeras: Induced Protein Degradation as a Therapeutic Strategy.
    Ottis P; Crews CM
    ACS Chem Biol; 2017 Apr; 12(4):892-898. PubMed ID: 28263557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: Principles and application.
    Ren YS; Li HL; Piao XH; Yang ZY; Wang SM; Ge YW
    Biochem Pharmacol; 2021 Dec; 194():114798. PubMed ID: 34678227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Light-Induced Protein Degradation with Photocaged PROTACs.
    Xue G; Wang K; Zhou D; Zhong H; Pan Z
    J Am Chem Soc; 2019 Nov; 141(46):18370-18374. PubMed ID: 31566962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted protein degradation as a powerful research tool in basic biology and drug target discovery.
    Wu T; Yoon H; Xiong Y; Dixon-Clarke SE; Nowak RP; Fischer ES
    Nat Struct Mol Biol; 2020 Jul; 27(7):605-614. PubMed ID: 32541897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Small-Molecule Conjugates: The Future is Now.
    Dal Corso A
    Chembiochem; 2020 Dec; 21(23):3321-3322. PubMed ID: 32893949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Deubiquitinating Enzymes and Autophagy in Cancer.
    Mooneyham A; Bazzaro M
    Methods Mol Biol; 2017; 1513():49-59. PubMed ID: 27807830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery.
    Jung HJ; Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1627-41. PubMed ID: 26040984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PROTACs and Other Chemical Protein Degradation Technologies for the Treatment of Neurodegenerative Disorders.
    Tomoshige S; Ishikawa M
    Angew Chem Int Ed Engl; 2021 Feb; 60(7):3346-3354. PubMed ID: 32410219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically Encoded Activators of Small Molecules for Imaging and Drug Delivery.
    Thiel Z; Nguyen J; Rivera-Fuentes P
    Angew Chem Int Ed Engl; 2020 May; 59(20):7669-7677. PubMed ID: 31898373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locus-Specific Knock-In of a Degradable Tag for Target Validation Studies.
    Brand M; Winter GE
    Methods Mol Biol; 2019; 1953():105-119. PubMed ID: 30912018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SNIPER peptide-mediated degradation of endogenous proteins.
    Fan X; Wang YT
    Curr Protoc Chem Biol; 2015 Mar; 7(1):1-16. PubMed ID: 25727059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small targeted cytotoxics from DNA-encoded chemical libraries.
    Samain F; Casi G
    Curr Opin Chem Biol; 2015 Jun; 26():72-9. PubMed ID: 25726911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods for the elucidation of protein-small molecule interactions.
    McFedries A; Schwaid A; Saghatelian A
    Chem Biol; 2013 May; 20(5):667-73. PubMed ID: 23706633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting protein-small molecule interactions using fluorous small-molecule microarrays.
    Vegas AJ; Koehler AN
    Methods Mol Biol; 2010; 669():43-55. PubMed ID: 20857356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical genetic control of protein levels: selective in vivo targeted degradation.
    Schneekloth JS; Fonseca FN; Koldobskiy M; Mandal A; Deshaies R; Sakamoto K; Crews CM
    J Am Chem Soc; 2004 Mar; 126(12):3748-54. PubMed ID: 15038727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.
    Ciechanover A
    Biochim Biophys Acta; 2012 Jan; 1824(1):3-13. PubMed ID: 21435401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.
    Sheng C; Dong G; Miao Z; Zhang W; Wang W
    Chem Soc Rev; 2015 Nov; 44(22):8238-59. PubMed ID: 26248294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.